Skip to main content
    H

    Helius Medical Technologies Inc Class A (HSDT)

    Official site

    FINANCIAL SERVICES • MEDICAL DEVICES • NASDAQ

    $2.35
    +0.13 (+5.86%)

    Market Cap: $153.00M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    58%(22/38)
    Avg Surprise
    -8137.90%

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.01
    Range$-0.04 - $0.02
    2 analysts
    EPS Revisions
    1
    0
    7d
    1
    1
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.01+33.3%
    60d ago$-0.01+33.3%
    30d ago$-0.01+33.3%
    7d ago$-0.010.0%
    Current$-0.01
    Revenue Consensus
    $3M
    Range$3M - $3M
    2 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-0.84
    Range$-0.84 - $-0.84
    1 analysts
    Revenue Consensus
    $3M
    Range$2M - $4M
    2 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.84---
    Sep 26EST
    		-$-0.01---
    Jun 26
    Reported Aug 14
    		$-0.05$-0.02-150.00%Miss+100.0%
    Mar 26
    Reported May 15
    		$-1.30$-0.84-54.76%Miss-29.0%
    Sep 25
    Reported Nov 18
    		$-32.89$-50.50+34.87%Beat+95.7%
    Jun 25
    Reported Aug 14
    		$-79.73$-128.50+37.95%Beat+83.4%
    Mar 25
    Reported May 1
    		$-391.72$-690.00+43.23%Beat+83.0%
    Dec 24
    Reported Mar 25
    		$-1.01$-0.94-7.17%Miss+31.5%
    Sep 24
    Reported Nov 12
    		$-769.50$-795.00+3.21%Beat+78.0%
    Jun 24
    Reported Aug 12
    		$-480.00$-375.00-28.00%Miss+78.7%
    Mar 24
    Reported May 13
    		$-2310.00$-3780.00+38.89%Beat+31.6%
    Dec 23
    Reported Mar 28
    		$-1.47N/A+61.01%Beat-764.7%
    Sep 23
    Reported Nov 9
    		$-3493.87$-4500.00+22.36%Beat+22.4%
    Jun 23
    Reported Aug 10
    		$-2250.00$-4375.00+48.57%Beat+93.8%
    Mar 23
    Reported May 11
    		$-3375.00$-4125.00+18.18%Beat-293378.3%
    Dec 22
    Reported Mar 9
    		$-0.17$-0.13-30.77%Miss+100.0%
    Sep 22
    Reported Nov 14
    		$-4500.00$-7875.00+42.86%Beat+94.0%
    Jun 22
    Reported Aug 15
    		$-36374.98$-41999.98+13.39%Beat+62.4%
    Mar 22
    Reported May 12
    		$-1.15$-1.13-1.77%Miss+30.3%
    Dec 21
    Reported Mar 14
    		$-49124.98$-43499.98-12.93%Miss+26.0%
    Sep 21
    Reported Nov 10
    		$-75374.96$-65624.97-14.86%Miss+28.2%
    Jun 21
    Reported Aug 12
    		$-96749.95$-60562.47-59.75%Beat+7.9%
    Mar 21
    Reported May 17
    		$-1.65$-1.51-9.27%Miss-1000.0%
    Dec 20
    Reported Mar 10
    		$-66374.97$-3000.00-2112.50%Beat+73.4%
    Sep 20
    Reported Nov 12
    		$-105000.05$-118125.06+11.11%Beat+63.6%
    Jun 20
    Reported Aug 12
    		$-105000.05$-157500.08+33.33%Beat-700.0%
    Mar 20
    Reported May 7
    		$-0.15N/A+97.32%Beat-100.0%
    Dec 19
    Reported Mar 12
    		$-249375.12$-275625.14+9.52%Beat-3392758.8%
    Sep 19
    Reported Nov 12
    		$-288750.14$-288750.14+0.00%Beat-15.8%
    Jun 19
    Reported Aug 8
    		$-13125.01N/A+95.56%Beat+98.7%
    Mar 19
    Reported May 9
    		$65625.03N/A+119.61%Beat+82031387.5%
    Dec 18
    Reported Mar 14
    		$-7.35$-7.17-2.51%Miss-3877.3%
    Sep 18
    Reported Nov 8
    		$-249375.12$-301875.15+17.39%Beat-37054152.6%
    Jun 18
    Reported Aug 9
    		$-1000000.00$-301875.15-231.26%Beat-333333233.3%
    Mar 18
    Reported May 9
    		$-0.08N/A-117.78%Miss+99.3%
    Dec 17
    Reported Mar 12
    		$-0.18$-0.15-23.20%Miss+100.0%
    Sep 17
    Reported Nov 10
    		$-0.67$-0.15-348.67%Miss-
    Jun 17
    Reported Aug 14
    		$-0.30$-0.05-500.00%Miss-
    Mar 17
    Reported Apr 3
    		$-12.25$-5.25-133.33%Miss-
    Dec 16
    Reported Feb 27
    		$-612.50$-0.20-306150.00%Miss-

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDA4.85x
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin-1293.00%
    ROE-179.00%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest Coverage0.79x
    Current Ratio13.31xQuick Ratio13.31x
    Trading Statistics
    Beta1.12Avg Volume649.07K
    52-Week High$12.1852-Week Low$1.19

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$2.46
    SMA 20$2.67
    SMA 50$2.29
    SMA 200$2.15
    EMA 10$2.43
    EMA 20$2.48
    EMA 50$2.34
    EMA 200$9.82

    MACD

    Line: -0.01Signal: 0.06Hist: -0.07

    ADX

    ADX: 24.0+DI: 20.0-DI: 27.2

    Aroon & PSAR

    Aroon Up32.0
    Aroon DownN/A
    PSAR$3.06

    Bollinger Bands

    Upper Band$3.22
    Lower Band$2.11
    %B Position4168%(Upper)
    Band Width0.21

    RSI (14-Day)

    Neutral
    45.4

    Momentum Oscillators

    Stoch %K10.2
    Stoch %D7.1
    Williams %R-78.7
    ROC (10d)-10.3%
    Momentum-0.27
    CCI (20d)-113.0
    MFI (14d)40.9

    Volatility Measures

    ATR (14d)$0.20(8.4%)
    StdDev (20d)0.28
    Hist Vol112.9%(High)

    Volume Flow

    VWAP$2.29
    OBV87.3M
    AD Line149.4B
    CMF (20d)-0.008

    Volume Metrics

    Avg Vol (20d)656.7K
    Vol Ratio1.3x
    VWMA (20d)$2.72

    Pivot Points

    R3$2.49
    R2$2.42
    R1$2.32
    Pivot Point$2.25
    S1$2.15
    S2$2.08
    S3$1.98

    Advanced Oscillators

    TSI-0.97
    Ultimate Osc41.0
    KST122.84

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$2.53M$3.62M$5.23M$697,000$43,000$49,000$152,000$51,000$182,000$135,000$134,000$143,000
    Cost of Revenue$77,000$180,000$180,000$103,000$96,000$121,000$154,000$187,000$118,000$123,000$90,000$187,000
    Gross Profit$2.45M$3.44M$5.05M$594,000$-53,000$-72,000$-2,000$-136,000$64,000$12,000$44,000$-44,000
    Operating Expenses$35.12M$103.06M$206.10M$36.04M$3.27M$3.94M$3.15M$3.93M$3.33M$3.43M$2.29M$3.11M
    R&D$0$0$886,000$858,000$0$0$924,000$1.08M$870,000$788,000$650,000$722,000
    SG&A$11.12M$5.19M$13.04M$4.65M$3.27M$3.94M$2.23M$2.86M$2.46M$2.63M$1.63M$2.20M
    Operating Income$-32,673,000$-99,618,000$-201,057,000$-35,450,000$-3,322,000$-4,011,000$-3,147,000$-4,070,000$-3,270,000$-3,416,000$-2,246,000$-3,153,000
    Interest Income$0$0$0$-1,000$0$0$-3,000$-1,000$-5,000$-8,000$0$68,000
    Interest Expense$0$181,000$0$194.74M$6.51M$0$781,000$0$0$0$0$510,000
    Income Before Tax$-30,256,000$-99,799,000$325.55M$-352,768,000$-9,833,000$-3,838,000$-3,928,000$-3,686,000$-1,612,000$-2,516,000$-1,045,000$-3,663,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-30,256,000$-99,799,000$325.55M$-352,768,000$-9,833,000$-3,838,000$-3,928,000$-3,686,000$-1,612,000$-2,516,000$-1,045,000$-3,663,000
    EBITDA$-30,256,000$-99,799,000$325.99M$-158,024,000$-9,833,000$-3,838,000$-3,925,000$-3,699,000$-1,591,000$-2,492,000$-1,024,000$-3,689,000
    EBIT$-30,256,000$-99,799,000$325.99M$-158,024,000$-9,833,000$-3,838,000$-3,925,000$-3,685,000$-1,607,000$-2,508,000$-1,045,000$-3,731,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about HSDT

    News

    No news available

    Company news will appear here when available

    HSDT Valuation and Fair Value

    EV/EBITDA
    4.8x
    PEG
    0.0x
    P/B
    1.1x
    See GNG's fair value

    HSDT Profitability: Margins, ROIC and FCF

    Gross margin
    95.5%
    Operating margin
    -1293.0%
    Net margin
    0.0%
    ROE
    -179.0%
    FCF margin
    -223.2%

    HSDT Competitors

    CompanyTicker
    Mediwound LtdMDWD
    JIN MEDICAL INTERNATIONAL LTD. Ordinary SharesZJYL
    OPTIMIZERx CorpOPRX
    Mersana Therapeutics IncMRSN
    Anbio Biotechnology Class A Ordinary SharesNNNN
    Sound Point Meridian Capital, Inc.SPMC
    Compass Therapeutics Inc.CMPX
    Organogenesis Holdings IncORGO

    Sector: Healthcare

    HSDT Bull Case vs Bear Case

    Bull case

    • HSDT grew quarterly revenue 5774.0% year over year.

    HSDT Earnings: Beat Rate and Next Report

    Beat rate
    4 of 8 quarters (50.0%)
    Average surprise
    -15.1%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.01
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    1 up, 1 down

    Frequently Asked Questions About HSDT

    Does HSDT pay dividends?

    Helius Medical Technologies Inc Class A (HSDT) does not currently pay a regular dividend.

    What is HSDT's market cap?

    Helius Medical Technologies Inc Class A (HSDT) has a market capitalization of $153.00M with a current stock price of $2.35.

    Related stocks

    Sector: Healthcare

    All stocks starting with H

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In